MEGAN ROMERO: Open Payments
NPI 1083327514 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,489 in 67 payments from 30 companies in 2025. Trend: 2023 $39 · 2024 $641 · 2025 $1,489
Food & beverage: $1,489
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 9 | $172 |
| Merck Sharp & Dohme LLC | 7 | $155 |
| Janssen Biotech, Inc. | 4 | $117 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $105 |
| AstraZeneca Pharmaceuticals LP | 4 | $88 |
| Eisai Inc. | 4 | $85 |
| Incyte Corporation | 4 | $80 |
| Medtronic, Inc. | 3 | $77 |
| TerSera Therapeutics LLC | 2 | $59 |
| Ipsen Biopharmaceuticals, Inc | 2 | $47 |
Products named: Enhertu, DARZALEX, Lenvima, ICLUSIG, JAKAFI, DATROWAY, KEYTRUDA, Zoladex.
Industry payments across FL — which companies pay providers there.
